Skip to main content
Erschienen in: Endocrine 2/2013

01.04.2013 | Original Article

Correlation of high urinary Smad1 level with glomerular hyperfiltration in type 2 diabetes mellitus

verfasst von: Wen-Jin Fu, Yao-Gao Fang, Ren-Tang Deng, Shu Wen, Mei-Lian Chen, Zhi-Hong Huang, Hui-Hua Tang, Shi-Long Xiong, Xian-Zhang Huang, Qian Wang

Erschienen in: Endocrine | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to assess the relationship between urinary Smad1 and glomerular hyperfiltration (GHF) in type 2 diabetes mellitus (T2DM), and to explore the factors related to the urinary Smad1 in T2DM. The reference value of the estimated glomerular filtration rate (eGFR) was determined in 248 healthy individuals. 30 patients with GHF, 58 patients with norm-GFR T2DM, and 24 healthy patients who served as controls were recruited. Urinary Smad1, fasting plasma glucose (FPG), fasting serum C-Peptide (C-P), hemoglobin A1C (HbA1c), cystatin C, and other chemistry laboratory parameters of T2DM participants and controls were measured. Patients with GHF had higher levels of urinary Smad1 than the control group, and those with norm-GFR. For T2DM patients with body mass index, age, and gender adjustments, urinary Smad1 was positively correlated with FPG, HbA1C, and eGFR, but negatively correlated with fasting serum C-P. Multivariate linear regression analysis demonstrated that eGFR, HbA1C, and fasting serum C-P were independently associated with urinary Smad1. High levels of urinary Smad1 were found in GHF patients with T2DM, which may be another potential mechanism of GHF in relation to diabetic nephropathy.
Literatur
1.
Zurück zum Zitat M. Krolewski, P.W. Eggers, J.H. Warram, Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int. 50, 2041–2046 (1996)PubMedCrossRef M. Krolewski, P.W. Eggers, J.H. Warram, Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int. 50, 2041–2046 (1996)PubMedCrossRef
2.
Zurück zum Zitat M. Bojestig, H.J. Arnqvist, G. Hermansson et al., Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N. Engl. J. Med. 330, 15–18 (1994)PubMedCrossRef M. Bojestig, H.J. Arnqvist, G. Hermansson et al., Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N. Engl. J. Med. 330, 15–18 (1994)PubMedCrossRef
3.
Zurück zum Zitat B.M. Brenner, Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int. 23, 647–655 (1983)PubMedCrossRef B.M. Brenner, Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int. 23, 647–655 (1983)PubMedCrossRef
4.
Zurück zum Zitat W.J. Fu, S.L. Xiong, Y.G. Fang et al., Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Endocrine 41, 82–88 (2012)PubMedCrossRef W.J. Fu, S.L. Xiong, Y.G. Fang et al., Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Endocrine 41, 82–88 (2012)PubMedCrossRef
5.
Zurück zum Zitat M. von Eynatten, M. Baumann, U. Heemann et al., Urinary L-FABP and anaemia: distinct roles of urinary markers in type diabetes. Eur. J. Clin. Investig. 40, 95–102 (2010)CrossRef M. von Eynatten, M. Baumann, U. Heemann et al., Urinary L-FABP and anaemia: distinct roles of urinary markers in type diabetes. Eur. J. Clin. Investig. 40, 95–102 (2010)CrossRef
6.
Zurück zum Zitat T. Matsubara, H. Abe, H. Arai et al., Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy. Lab. Investig. 86(4), 357–368 (2006)PubMedCrossRef T. Matsubara, H. Abe, H. Arai et al., Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy. Lab. Investig. 86(4), 357–368 (2006)PubMedCrossRef
7.
Zurück zum Zitat P.A. Hoodless, T. Haerry, S. Abdollah et al., MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85, 489–500 (1996)PubMedCrossRef P.A. Hoodless, T. Haerry, S. Abdollah et al., MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85, 489–500 (1996)PubMedCrossRef
8.
Zurück zum Zitat M. Wang, H. Jin, D. Tang et al., Smad1 plays an essential role in bone development and postnatal bone formation. Osteoarthritis Cartil. 19(6), 751–762 (2011)CrossRef M. Wang, H. Jin, D. Tang et al., Smad1 plays an essential role in bone development and postnatal bone formation. Osteoarthritis Cartil. 19(6), 751–762 (2011)CrossRef
9.
Zurück zum Zitat K.D. Tremblay, N.R. Dunn, E. Robertson, Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 28, 3609–3621 (2001) K.D. Tremblay, N.R. Dunn, E. Robertson, Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 28, 3609–3621 (2001)
10.
Zurück zum Zitat Rosolowsky ET, Niewczas MA, Ficociello LH, et al., Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy. Diabetes. Res. Clin. Pract. 13(S1), S46–53 (2008) Rosolowsky ET, Niewczas MA, Ficociello LH, et al., Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy. Diabetes. Res. Clin. Pract. 13(S1), S46–53 (2008)
11.
Zurück zum Zitat B.M. Brenner, T.W. Meyer, T.H. Hostetter, Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N. Engl. J. Med. 307, 652–659 (1982)PubMedCrossRef B.M. Brenner, T.W. Meyer, T.H. Hostetter, Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N. Engl. J. Med. 307, 652–659 (1982)PubMedCrossRef
12.
Zurück zum Zitat M.P. O’Donnell, B.L. Kasiske, W.F. Keane, Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J. 2(8), 2339–2344 (1988)PubMed M.P. O’Donnell, B.L. Kasiske, W.F. Keane, Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J. 2(8), 2339–2344 (1988)PubMed
13.
Zurück zum Zitat G. Gruden, S. Thomas, D. Burt et al., Mechanical stretch induces vascular permeability factor in human mesangial cells: Mechanisms of signal transduction Proc. Natl. Acad. Sci. USA 94, 12112–12116 (1997)CrossRef G. Gruden, S. Thomas, D. Burt et al., Mechanical stretch induces vascular permeability factor in human mesangial cells: Mechanisms of signal transduction Proc. Natl. Acad. Sci. USA 94, 12112–12116 (1997)CrossRef
14.
Zurück zum Zitat W.J. Fu, B.L. Li, S.B. Wang et al., Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration. Diabetes Res. Clin. Pract. 95(1), 105–109 (2012)PubMedCrossRef W.J. Fu, B.L. Li, S.B. Wang et al., Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration. Diabetes Res. Clin. Pract. 95(1), 105–109 (2012)PubMedCrossRef
15.
Zurück zum Zitat R.J. Macisaac, C. Tsalamandris, M.C. Thomas et al., Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia 49, 1686–1689 (2006)PubMedCrossRef R.J. Macisaac, C. Tsalamandris, M.C. Thomas et al., Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia 49, 1686–1689 (2006)PubMedCrossRef
16.
Zurück zum Zitat L.H. Ficociello, B.A. Perkins, B. Roshan et al., Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care 32, 889–893 (2009)PubMedCrossRef L.H. Ficociello, B.A. Perkins, B. Roshan et al., Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care 32, 889–893 (2009)PubMedCrossRef
17.
Zurück zum Zitat R. Bruce, M. Rutland, T. Cundy, Glomerular hyperfiltration in young Polynesians with type 2 diabetes. Diab. Res. Clin. Pract. 25, 155–160 (1994)CrossRef R. Bruce, M. Rutland, T. Cundy, Glomerular hyperfiltration in young Polynesians with type 2 diabetes. Diab. Res. Clin. Pract. 25, 155–160 (1994)CrossRef
18.
Zurück zum Zitat P. Vedel, J. Obel, F.S. Nielsen et al., Glomerular hyperfiltration in microalbuminuric NIDD patients. Diabetologia 39, 1584–1589 (1996)PubMedCrossRef P. Vedel, J. Obel, F.S. Nielsen et al., Glomerular hyperfiltration in microalbuminuric NIDD patients. Diabetologia 39, 1584–1589 (1996)PubMedCrossRef
19.
Zurück zum Zitat C.K. Keller, K.H. Bergis, D. Fliser, E. Ritz, Renal findings in patients with short-term type 2 diabetes. J. Am. Soc. Nephrol. 7, 2627–2635 (1996)PubMed C.K. Keller, K.H. Bergis, D. Fliser, E. Ritz, Renal findings in patients with short-term type 2 diabetes. J. Am. Soc. Nephrol. 7, 2627–2635 (1996)PubMed
20.
Zurück zum Zitat S.P. Silviero, R. Friedman, M.J. Azevedo et al., Five year prospective study of the glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients. Diabetes Care 19, 171–174 (1996)CrossRef S.P. Silviero, R. Friedman, M.J. Azevedo et al., Five year prospective study of the glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients. Diabetes Care 19, 171–174 (1996)CrossRef
21.
Zurück zum Zitat G.D. Tan, A.V. Lewis, T.J. James et al., Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care 25, 2004–2009 (2002)PubMedCrossRef G.D. Tan, A.V. Lewis, T.J. James et al., Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care 25, 2004–2009 (2002)PubMedCrossRef
22.
Zurück zum Zitat Y. Jin, T. Moriya, K. Tanaka et al., Glomerular hyperfiltration in non-proteinuric and non-hypertensive Japanese type 2 diabetic patients. Diabetes Res. Clin. Pract. 71, 264–271 (2006)PubMedCrossRef Y. Jin, T. Moriya, K. Tanaka et al., Glomerular hyperfiltration in non-proteinuric and non-hypertensive Japanese type 2 diabetic patients. Diabetes Res. Clin. Pract. 71, 264–271 (2006)PubMedCrossRef
23.
Zurück zum Zitat A. Mima, H. Arai, T. Matsubara et al., Urinary Smad1 is a novel marker to predict later on set of mesangial matrix expansion in diabetic nephropathy. Diabetes 57(6), 1712–1722 (2008)PubMedCrossRef A. Mima, H. Arai, T. Matsubara et al., Urinary Smad1 is a novel marker to predict later on set of mesangial matrix expansion in diabetic nephropathy. Diabetes 57(6), 1712–1722 (2008)PubMedCrossRef
24.
Zurück zum Zitat G. Gruden, S. Zonca, A. Hayward et al., Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes 49(4), 655–661 (2000)PubMedCrossRef G. Gruden, S. Zonca, A. Hayward et al., Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes 49(4), 655–661 (2000)PubMedCrossRef
25.
Zurück zum Zitat S.W. Hong, M. Isono, S. Chen et al., Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am. J. Pathol. 158(5), 1653–1663 (2001)PubMedCrossRef S.W. Hong, M. Isono, S. Chen et al., Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am. J. Pathol. 158(5), 1653–1663 (2001)PubMedCrossRef
26.
Zurück zum Zitat H. Jia, L. Yu, B. Gao, Q. Ji, Association between the T869C polymorphism of transforming growth factor-beta 1 and diabetic nephropathy: a meta-analysis. Endocrine 40(3), 372–378 (2011)PubMedCrossRef H. Jia, L. Yu, B. Gao, Q. Ji, Association between the T869C polymorphism of transforming growth factor-beta 1 and diabetic nephropathy: a meta-analysis. Endocrine 40(3), 372–378 (2011)PubMedCrossRef
27.
Zurück zum Zitat H. Abe, T. Matsubara, H. Arai et al., Role of Smad1 in diabetic nephropathy: molecular mechanisms and implications as a diagnostic marker. Histol. Histopathol. 26(4), 531–541 (2011)PubMed H. Abe, T. Matsubara, H. Arai et al., Role of Smad1 in diabetic nephropathy: molecular mechanisms and implications as a diagnostic marker. Histol. Histopathol. 26(4), 531–541 (2011)PubMed
28.
Zurück zum Zitat C.E. Hills, N. Al-Rasheed, N. Al-Rasheed et al., C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 296(3), F614–F621 (2009)PubMedCrossRef C.E. Hills, N. Al-Rasheed, N. Al-Rasheed et al., C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 296(3), F614–F621 (2009)PubMedCrossRef
29.
Zurück zum Zitat C.E. Hills, N.J. Brunskill, P.E. Squires, C-peptide as a therapeutic tool in diabetic nephropathy. Am. J. Nephrol. 31(5), 389–397 (2010)PubMedCrossRef C.E. Hills, N.J. Brunskill, P.E. Squires, C-peptide as a therapeutic tool in diabetic nephropathy. Am. J. Nephrol. 31(5), 389–397 (2010)PubMedCrossRef
Metadaten
Titel
Correlation of high urinary Smad1 level with glomerular hyperfiltration in type 2 diabetes mellitus
verfasst von
Wen-Jin Fu
Yao-Gao Fang
Ren-Tang Deng
Shu Wen
Mei-Lian Chen
Zhi-Hong Huang
Hui-Hua Tang
Shi-Long Xiong
Xian-Zhang Huang
Qian Wang
Publikationsdatum
01.04.2013
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2013
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9741-9

Weitere Artikel der Ausgabe 2/2013

Endocrine 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.